PAPADOPOULOS STELIOS 1202098 Data last updated 2024-05-11 06:58:14 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-02 | 2023-06-01 | 2023-06-01 | 4 | Papadopoulos Stelios | DIRECTOR | acq | 20718.0 | 1.64 | 0.64 | 0.0 | Direct | Common Stock | EXELIXIS, INC. | code A | 1260329.0 | 325.64 (EXEL) |
| 2024-03-15 | 2024-03-14 | 2024-03-14 | 4 | Papadopoulos Stelios | DIRECTOR | acq | 250000.0 | 25.55 | 123.62 | 1.6 | Direct | Common Stock | REGULUS THERAPEUTICS INC. | code A | 978388.0 | 20.22 (RGLS) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-13 | 2023-06-13 | 2023-06-13 | 4 | Papadopoulos Stelios | DIRECTOR | acq | 30000.0 | 100.0 | 15.4 | 1.45 | Direct | Stock Option (Right To Buy) | REGULUS THERAPEUTICS INC. | code A | 30000.0 | 19.48 (RGLS) |
| 2023-08-14 | 2023-08-10 | 2023-08-10 | 4 | Papadopoulos Stelios | DIRECTOR | acq | 15000.0 | 100.0 | 7.7 | 1.36 | Direct | Stock Option (Right To Buy) | REGULUS THERAPEUTICS INC. | code A | 15000.0 | 19.48 (RGLS) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)